Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234149 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 10 Pages |
Abstract
Stomach cancer risk is strongly radiation dose dependent. The role of chemotherapy, particularly of procarbazine and related agents, needs further study, because of the relatively small numbers of chemotherapy-treated subjects.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alexandra W. M.Sc., Berthe M.P. M.D., Ph.D., Gijs M.Sc., Marie L. Ph.D., Michael Ph.D., Mars B. M.D., Ph.D., Ronald M.D., Ph.D., Jacques G. M.D., Evert M. M.D., Ph.D., J. Martijn M.D., Ph.D., Jourik A. M.D., Ph.D., Flora E. Ph.D.,